About Us

The CRPP^MS is closed, please find relevant information about the new CRPP Precision MS here.

Our Research Network

The CRPP Multiple Sclerosis is a joint venture of the University Hospital Zurich (USZ), the University of Zurich (UZH), the ETH Zurich (ETH) and the Paul-Scherrer-Institute in Villingen (PSI). The following institutes and departments are participating:

University Hospital Zurich/University of Zurich

• Neuroimmunology and MS Research, Department of Neurology (R. Martin, S. Schippling, A.Lutterotti and M. Sospedra Ramos)
• Department of Ophthalmology (K. Landau/C. Gerth-Kahlert)

University of Zurich

• Institute of Experimental Immunology, Department of Viral Immunobiology (C. Münz)

ETH Zurich

• Institute of Pharmaceutical Sciences (R. Schibli/S. Ametamey)

ETH Zurich & University of Zurich

• Institute for Biomedical Engineering, Molecular Imaging and Functional Pharmacology (M. Rudin)
• Institute for Biomedical Engineering, Translational Neuromodeling Unit (K. E. Stephan)

Paul Scherrer Institute, Villingen

• Center for Radiopharmaceutical Sciences (R. Schibli)

External Collaborations and Project Partners

• Swiss MS Society
• UK MS Tissue Bank, London, UK - Prof. Richard Reynolds
• ETIMSred (supervised by A. Lutterotti and R. Martin) is a project of the Wyss Translational Center Zürich ETIMSred
• Max Planck Institute for Biological Cybernetics, Tübingen, Germany - Dr. Anke Henning

Principle investigators (PIs in alphabetical order)

Advisory Board

Henry McFarland, Emeritus professor at NIH, Bethesda, USA
Wolfgang Brück, Professor at Universitätsmedizin Göttingen, Germany
Tomas Olsson, Professor at Karolinska Institute, Stockholm, Sweden